tBE Editing Shows Durable Hemoglobin Correction in Four Patients
Investigators reported four recipients of autologous hematopoietic stem and progenitor cells edited ex vivo with tBE, a transformer base editor intended to reactivate fetal hemoglobin. One participant had sickle cell disease and three had…
